Patrícia Ic. Morgado
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Patrícia Ic. Morgado has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Ilídio Joaquim Correia
RISE-Health, Departamento de Ciências Médicas, Faculdade de Ciências da Saúde, Universidade da Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal; AEROG-LAETA, Aerospace Sciences Department, Universidade da Beira Interior, Covilhã, Portugal; University of Coimbra, CERES - Centro de Engenharia Química e Recursos Renováveis para a Sustentabilidade, Department of Chemical Engineering, Coimbra 3030-790, Portugal
7 shared publications - Ana Aguiar-Ricardo
LAQV-REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, Campus de Caparica, Caparica 2829-516, Portugal
5 shared publications - Maximiano Prata Ribeiro
Polytechnic Institute of Guarda
4 shared publications - Sonia P. Miguel
BRIDGES ‐ Biotechnology Research Innovation and Design for Health Products Polytechnic of Guarda Guarda Portugal
2 shared publications - Vasco D. B. Bonifácio
BB-Institute for Bioengineering and Biosciences and i4HB-Institute for Health and Bioeconomy, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001 Lisboa, Portugal
2 shared publications - Abilio Pereira Silva
UBI - University of Beira Interior
1 shared publication
Latest Publications
- 25 November 2019
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 6 (1) , 012002
In situ injectable hydrogels for spinal cord regeneration: advances from the last 10 years
Spinal cord injury (SCI) is a tremendously devastating disorder with no effective therapy. Neuroprotective strategies have been applied aiming to prevent secondary cell death but no successful and robust effects have been observed. Recently, combinatorial approaches using biomaterials with cells and/or growth factors have demonstrated promising therapeutic effects because of the improvement of axonal growth and in vivo functional recovery in model organisms. In situ injectable hydrogels are a particularly attractive neuroregenerative approach to improve spinal cord repair and regeneration since they can be precisely injected into the lesion site filling the space prior to gelification, decrease scarring and promote axon growth due to the hydrogel’s soft structure. Important advances regarding the use of hydrogels as potential therapeutic approaches has been reported during the last 10 years. Injectable alginate hydrogel loaded with GDNF, thermoresponsives heparin-poloxamer loaded with NGF and imidazole-poly(organophosphazenes) hydrogels are just three examples of biomaterials that can promote neurite, axon growth and improve functional recovery in hemisected and resected rats. Here we will review the status of in situ injectable hydrogels for spinal cord regeneration with special focus in the advantages of using hydrogel scaffolds, the ideal polymers to be used, the gelification process and the cells or growth factors combined. The in vitro and in vivo results reported for those biomaterials will be presented, compared and discussed.
- 25 November 2019
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 6 (1) , 012002
In situ injectable hydrogels for spinal cord regeneration: advances from the last 10 years
Spinal cord injury (SCI) is a tremendously devastating disorder with no effective therapy. Neuroprotective strategies have been applied aiming to prevent secondary cell death but no successful and robust effects have been observed. Recently, combinatorial approaches using biomaterials with cells and/or growth factors have demonstrated promising therapeutic effects because of the improvement of axonal growth and in vivo functional recovery in model organisms. In situ injectable hydrogels are a particularly attractive neuroregenerative approach to improve spinal cord repair and regeneration since they can be precisely injected into the lesion site filling the space prior to gelification, decrease scarring and promote axon growth due to the hydrogel’s soft structure. Important advances regarding the use of hydrogels as potential therapeutic approaches has been reported during the last 10 years. Injectable alginate hydrogel loaded with GDNF, thermoresponsives heparin-poloxamer loaded with NGF and imidazole-poly(organophosphazenes) hydrogels are just three examples of biomaterials that can promote neurite, axon growth and improve functional recovery in hemisected and resected rats. Here we will review the status of in situ injectable hydrogels for spinal cord regeneration with special focus in the advantages of using hydrogel scaffolds, the ideal polymers to be used, the gelification process and the cells or growth factors combined. The in vitro and in vivo results reported for those biomaterials will be presented, compared and discussed.
- 21 July 2017
- Published by Oxford University Press (OUP) in Environmental Toxicology and Chemistry
- Vol. 36 (12) , 3404-3414
Integration of cellular and molecular endpoints to assess the toxicity of polycyclic aromatic hydrocarbons in HepG2 cell line
Polycyclic aromatic hydrocarbons (PAHs) are persistent pollutants present in the environment with known mutagenic and carcinogenic properties. In the present study the effects of exposure to single or multiple doses of benzo[a]anthracene (BaA), pyrene (Pyr), and 3 halogenated derivatives of these compounds (1-chloropyrene, 1-bromopyrene [1-BrPyr], and 7-chlorobenzo[a]anthracene [7-ClBaA]) were evaluated in a liver-derived human cell line (HepG2). Cytotoxicity as assessed by the classic 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and neutral red assays showed a mild toxic effect in response to single or multiple dose exposure for up to 72 h, except for multiple dose exposure to BaA and 7-ClBaA (1 μM/d for 4 d) and single exposure to 10 μM BaA. Furthermore, selective mitochondrial and lysosomal toxicity was observed for Pyr and BaA series, respectively. To understand the underlying molecular mechanisms responsible for this effect, reactive oxygen species production, mitochondrial membrane depolarization, lysosomal pH, DNA fragmentation, and early and late apoptosis mediators were evaluated after exposure to single doses of the compounds. All compounds were able to trigger oxidative stress after 24 h as measured by catalase activity, and a good correlation was found between mitochondrial membrane depolarization, lysosomal pH increase, and MTT and neutral red assays. Evaluation of cell death mediators showed that caspase-3/7, but not annexin-V, pathways were involved in toxicity triggered by the studied compounds. The integration of all results showed that 1-BrPyr and BaA have a higher toxicity potential. Environ Toxicol Chem 2017;36:3404–3414. © 2017 SETAC
- 21 July 2017
- Published by Oxford University Press (OUP) in Environmental Toxicology and Chemistry
- Vol. 36 (12) , 3404-3414
Integration of cellular and molecular endpoints to assess the toxicity of polycyclic aromatic hydrocarbons in HepG2 cell line
Polycyclic aromatic hydrocarbons (PAHs) are persistent pollutants present in the environment with known mutagenic and carcinogenic properties. In the present study the effects of exposure to single or multiple doses of benzo[a]anthracene (BaA), pyrene (Pyr), and 3 halogenated derivatives of these compounds (1-chloropyrene, 1-bromopyrene [1-BrPyr], and 7-chlorobenzo[a]anthracene [7-ClBaA]) were evaluated in a liver-derived human cell line (HepG2). Cytotoxicity as assessed by the classic 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and neutral red assays showed a mild toxic effect in response to single or multiple dose exposure for up to 72 h, except for multiple dose exposure to BaA and 7-ClBaA (1 μM/d for 4 d) and single exposure to 10 μM BaA. Furthermore, selective mitochondrial and lysosomal toxicity was observed for Pyr and BaA series, respectively. To understand the underlying molecular mechanisms responsible for this effect, reactive oxygen species production, mitochondrial membrane depolarization, lysosomal pH, DNA fragmentation, and early and late apoptosis mediators were evaluated after exposure to single doses of the compounds. All compounds were able to trigger oxidative stress after 24 h as measured by catalase activity, and a good correlation was found between mitochondrial membrane depolarization, lysosomal pH increase, and MTT and neutral red assays. Evaluation of cell death mediators showed that caspase-3/7, but not annexin-V, pathways were involved in toxicity triggered by the studied compounds. The integration of all results showed that 1-BrPyr and BaA have a higher toxicity potential. Environ Toxicol Chem 2017;36:3404–3414. © 2017 SETAC
- 1 September 2015
- Published by Elsevier in Journal of Membrane Science
- Vol. 490, 139-151
Asymmetric membranes as ideal wound dressings: An overview on production methods, structure, properties and performance relationship
- 1 September 2015
- Published by Elsevier in Journal of Membrane Science
- Vol. 490, 139-151
Asymmetric membranes as ideal wound dressings: An overview on production methods, structure, properties and performance relationship
- Open Access
- 6 November 2014
- Published by The Royal Society in Journal of The Royal Society Interface
- Vol. 11 (100) , 20140743
An extracellular polymer at the interface of magnetic bioseparations
FucoPol, a fucose-containing extracellular polysaccharide (EPS) produced by bacterium Enterobacter A47 using glycerol as the carbon source, was employed as a coating material for magnetic particles (MPs), which were subsequently functionalized with an artificial ligand for the capture of antibodies. The performance of the modified MPs (MP–EPS-22/8) for antibody purification was investigated using direct magnetic separation alone or combined with an aqueous two-phase system (ATPS) composed of polyethylene glycol (PEG) and dextran. In direct magnetic capturing, and using pure protein solutions of human immunoglobulin G (hIgG) and bovine serum albumin (BSA), MP–EPS-22/8 bound 120 mg hIgG g −1 MPs, whereas with BSA only 10 ± 2 mg BSA g −1 MPs was achieved. The hybrid process combining both the ATPS and magnetic capturing leads to a good performance for partitioning of hIgG in the desired phase as well as recovery by the magnetic separator. The MPs were able to bind 145 mg of hIgG g −1 of particles which is quite high when compared with direct magnetic separation. The theoretical maximum capacity was calculated to be 410 ± 15 mg hIgG adsorbed g −1 MPs with a binding affinity constant of 4.3 × 10 4 M −1 . In multiple extraction steps, the MPs bound 92% of loaded hIgG with a final purity level of 98.5%. The MPs could easily be regenerated, recycled and re-used for five cycles with only minor loss of capacity. FucoPol coating allowed both electrostatic and hydrophobic interactions with the antibody contributing to enhance the specificity for the targeted products.
- 6 November 2014
- Published by The Royal Society in Journal of The Royal Society Interface
- Vol. 11 (100) , 20140743
Open AccessAn extracellular polymer at the interface of magnetic bioseparations
FucoPol, a fucose-containing extracellular polysaccharide (EPS) produced by bacterium Enterobacter A47 using glycerol as the carbon source, was employed as a coating material for magnetic particles (MPs), which were subsequently functionalized with an artificial ligand for the capture of antibodies. The performance of the modified MPs (MP–EPS-22/8) for antibody purification was investigated using direct magnetic separation alone or combined with an aqueous two-phase system (ATPS) composed of polyethylene glycol (PEG) and dextran. In direct magnetic capturing, and using pure protein solutions of human immunoglobulin G (hIgG) and bovine serum albumin (BSA), MP–EPS-22/8 bound 120 mg hIgG g −1 MPs, whereas with BSA only 10 ± 2 mg BSA g −1 MPs was achieved. The hybrid process combining both the ATPS and magnetic capturing leads to a good performance for partitioning of hIgG in the desired phase as well as recovery by the magnetic separator. The MPs were able to bind 145 mg of hIgG g −1 of particles which is quite high when compared with direct magnetic separation. The theoretical maximum capacity was calculated to be 410 ± 15 mg hIgG adsorbed g −1 MPs with a binding affinity constant of 4.3 × 10 4 M −1 . In multiple extraction steps, the MPs bound 92% of loaded hIgG with a final purity level of 98.5%. The MPs could easily be regenerated, recycled and re-used for five cycles with only minor loss of capacity. FucoPol coating allowed both electrostatic and hydrophobic interactions with the antibody contributing to enhance the specificity for the targeted products.
- 1 November 2014
- Published by Elsevier in Journal of Membrane Science
- Vol. 469, 262-271
Poly(vinyl alcohol)/chitosan asymmetrical membranes: Highly controlled morphology toward the ideal wound dressing
- 1 November 2014
- Published by Elsevier in Journal of Membrane Science
- Vol. 469, 262-271
Poly(vinyl alcohol)/chitosan asymmetrical membranes: Highly controlled morphology toward the ideal wound dressing
- 1 July 2013
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 33 (5) , 2958-2966
Dextran-based hydrogel containing chitosan microparticles loaded with growth factors to be used in wound healing
- 1 July 2013
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 33 (5) , 2958-2966
Dextran-based hydrogel containing chitosan microparticles loaded with growth factors to be used in wound healing
- 1 January 2013
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 39 (1) , 64-69
Dual on–off and off–on switchable oligoaziridine biosensor
- 1 January 2013
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 39 (1) , 64-69
Dual on–off and off–on switchable oligoaziridine biosensor
- Open Access
- 1 January 2013
- Published by SAGE Publications in Journal of Applied Biomaterials & Functional Materials
- Vol. 11 (1) , 18-25
Characterization of the Mechanical and Biological Properties of a New Alumina Scaffold
Purpose: In this work, an alumina scaffold was produced through a new method to be used in a near future as a bone substitute. Methods: In vitro and in vivo studies were performed in order to characterize the mechanical and biological properties of the scaffold. Results: The results obtained showed that this scaffold has high mechanical resistance and a porous surface that allows human osteoblast cells to adhere and proliferate. The in vivo studies revealed no systemic reaction. Conclusions: The alumina scaffold produced herein has the mechanical and biological properties that are compatible with its application in bone therapy.
- 1 January 2013
- Published by SAGE Publications in Journal of Applied Biomaterials & Functional Materials
- Vol. 11 (1) , 18-25
Open AccessCharacterization of the Mechanical and Biological Properties of a New Alumina Scaffold
Purpose: In this work, an alumina scaffold was produced through a new method to be used in a near future as a bone substitute. Methods: In vitro and in vivo studies were performed in order to characterize the mechanical and biological properties of the scaffold. Results: The results obtained showed that this scaffold has high mechanical resistance and a porous surface that allows human osteoblast cells to adhere and proliferate. The in vivo studies revealed no systemic reaction. Conclusions: The alumina scaffold produced herein has the mechanical and biological properties that are compatible with its application in bone therapy.
- 5 April 2012
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 51 (21) , 5162-5165
Biocompatible Polyurea Dendrimers with pH‐Dependent Fluorescence
- 5 April 2012
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 51 (21) , 5162-5165
Biocompatible Polyurea Dendrimers with pH‐Dependent Fluorescence
- 1 September 2011
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 416 (1) , 61-68
Development of 2-(dimethylamino)ethyl methacrylate-based molecular recognition devices for controlled drug delivery using supercritical fluid technology
- 1 September 2011
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 416 (1) , 61-68
Development of 2-(dimethylamino)ethyl methacrylate-based molecular recognition devices for controlled drug delivery using supercritical fluid technology